Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
The IPO pipeline in Hong Kong looks even stronger as of last week, after numerous draft prospectuses were filed. Notable deals include WeDoctor (1737089D HK), WM Tech (owner of Wumart Stores in China, and Medlive Tech (online professional physician network in China).
For upcoming debuts, Linklogis (LINK HK) closed a day earlier and priced above the midpoint of its IPO price range. The company is due to trade this coming Friday. We covered the IPO earlier in:
We initiated coverage on Nayuki Holdings (NYK HK), a popular premium teahouse chain in China, and Zhaoke Ophthalmology Pharmaceutical (ZKO HK), a China-based ophthalmic pharmaceutical company, earlier this week:
Nayuki (奈雪) Pre-IPO - Fast-Growing, Cash Flow Positive Teahouse Chain
Zhaoke Ophthalmic (兆科眼科): Could Be Over-Valued for Pre-IPO Round
In the US, bookbuild for Smart Share Global (EM US) was short. Books opened Monday, priced on Wednesday, ADS debuted on Thursday. SSG’s share price struggled in early hours of trading and closed flat, even after pricing below their initial price range. We covered the IPO in:
In India this week, we initiated coverage on Power Grid Corporation Of India (PWGR IN) and revisited Macrotech Developers (LODHA IN), which was previously known as Lodha Developers. Anchor books are set to open this coming Tuesday:
POWERGRID InvIT Pre-IPO - Always Going to Be Tricky with a Declining Yield
Macrotech (Lodha) Developers Pre-IPO - New Name but up to Some of the Same Old Tricks
Lodha Developers Pre-IPO - Second Time Lucky but Not Really that Much Affordable.
Last, but not least, in Australia, we covered Peter Warren’s IPO which is set to list close to the end of the month.
Our overall accuracy rate is 73.9% for IPOs and 67.1% for Placements
(Performance measurement criteria is explained at the end of the note)
Hong Kong
U.S. China ADRs
India
Philippines
Australia
Singapore
Japan
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.